NCT02665832View on ClinicalTrials.gov

Study of DWJ1351 in Healthy Male Volunteers

PHASE1UnknownINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Healthy
Interventions
DRUG

DWJ1351

DRUG

Co-administration of Sevikar (Olmesartan/Amlodipine) and Crestor (Rosuvastatin)

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY